<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000269413">
  <TermName>brostallicin hydrochloride</TermName>
  <TermPronunciation>(brah-STAH-lih-sin HY-droh-KLOR-ide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. Brostallicin hydrochloride binds to DNA and may kill cancer cells.  It may also help other drugs kill cancer cells. It is a type of DNA minor groove binding agent.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000709937" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;brostallicin hydrochloride&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000709938" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de brostalicina&quot;" language="es" id="_4"/>
  <SpanishTermName>clorhidrato de brostalicina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. El clorhidrato de brostalicina se une al ADN y es posible que elimine células cancerosas. A veces, también ayuda a otros medicamentos a destruir células cancerosas. Es un tipo de sustancia que aglutina los surcos menores del ADN.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2002-12-21</DateFirstPublished>
  <DateLastModified>2009-11-13</DateLastModified>
</GlossaryTerm>
